The PBAC has raised concerns that people with Crohn’s disease are staying on biologic medicines longer than expected, contributing to a blow-out in PBS costs. But an expert has told the limbic that the high rate of biologic continuation was a positive sign that patients were responding well to treatment and getting on with their ...
DUSC report a good news story for patients: Expert
By Tessa Hoffman
9 Nov 2017